Intended for healthcare professionals

Letters Opening up data at the EMA

Still waiting for functional EU Clinical Trials Register

BMJ 2011; 342 doi: (Published 20 June 2011) Cite this as: BMJ 2011;342:d3834
  1. Beate Wieseler, deputy head, Department of Drug Assessment1,
  2. Natalie McGauran, researcher1,
  3. Thomas Kaiser, head, Department of Drug Assessment1
  1. 1Institute for Quality and Efficiency in Health Care, 51105 Cologne, Germany
  1. beate.wieseler{at}

Gøtzsche and Jørgensen’s comprehensive account of their efforts to obtain clinical trial data from the European Medicines Agency (EMA) highlights the problems researchers still face in healthcare evaluation.1 In its response, the EMA refers to the steps it has undertaken to improve transparency, including the long awaited launch of the EU Clinical Trials Register (EU-CTR).2

The major goal of trial …

View Full Text

Log in

Log in through your institution


* For online subscription